Chemotherapy-induced late transgenerational effects in mice

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Kujjo, Loro L ^a,b   Chang, Eun A ^a   Pereira, Ricardo J G ^a   Dhar, Shilpa ^a   Marrero Rosado, Brenda ^a   Sengupta, Satyaki ^a   Wang, Hongbing ^a   Cibelli, Jose B ^a,c   Perez, Gloria I ^a,c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c LARCel   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; PROTEIN BAX; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1-PHOSPHATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CHROMOSOME 10; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE MUTATION; HEALTH STATUS; HOPELESSNESS; MALE; MATERNAL MORTALITY; NEWBORN; NEWBORN DEATH; NONHUMAN; OOCYTE; PRIMORDIAL GERM CELL; PROGENY; REPRODUCTION; REPRODUCTIVE TOXICITY; SINGLE DRUG DOSE; ANIMAL; ATROPHY; C57BL MOUSE; CHROMOSOME; DRUG EFFECT; GENETICS; HEREDITY; HUMAN; METABOLISM; MOUSE; MYOMETRIUM; OVARY FOLLICLE; OVULATION; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SPERMATOZOON; TRANSPLANTATION; UTERUS;

MUS; RODENTIA;

ANIMALS; ANTINEOPLASTIC AGENTS; ANXIETY; ATROPHY; BCL-2-ASSOCIATED X PROTEIN; BEHAVIOR, ANIMAL; CHROMOSOME DELETION; CHROMOSOMES, MAMMALIAN; DOXORUBICIN; FEMALE; HEREDITY; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; MYOMETRIUM; OOCYTES; OVARIAN FOLLICLE; OVULATION; PHENOTYPE; REPRODUCTION; SPERMATOZOA; SPHINGOSINE; UTERUS;

EID: 79952757448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017877     Document Type: Article

References (76)

1. Bath LE, Wallace WH, Critchley HO, (2002) Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. Bjog 109: 107-114.
2. Critchley HO, Wallace WH, (2007) Do survivors of childhood cancer have increased incidence of premature menopause? Nat Clin Pract Oncol 4: 84-85.
3. Fox E, Citrin D, Balis FM, (2009) The legacy of cancer therapy in children. J Natl Cancer Inst 101: 1105-1107.
4. Green DM, (2007) Long-term complications of treatment of children and adolescents with cancer: gene polymorphisms and causes of excess mortality. Pediatr Blood Cancer 48: 718.
5. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, et al. (2009) Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 27: 2677-2685.
6. Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, et al. (2009) Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol 27: 2374-2381.
7. Nakayama K, Milbourne A, Schover LR, Champlin RE, Ueno NT, (2008) Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers. Nat Clin Pract Oncol 5: 78-89.
8. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, et al. (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358: 271-276.
9. Schover LR, (2008) Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 26: 753-758.
10. Signorello LB, Cohen SS, Bosetti C, Stovall M, Kasper CE, et al. (2006) Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst 98: 1453-1461.
11. Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, et al. (2010) Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet 376: 624-630.
12. Winther JF, Boice JD Jr, Svendsen AL, Frederiksen K, Stovall M, et al. (2008) Spontaneous abortion in a Danish population-based cohort of childhood cancer survivors. J Clin Oncol 26: 4340-4346.
13. Oktay K, Sonmezer M, (2008) Chemotherapy and amenorrhea: risks and treatment options. Curr Opin Obstet Gynecol 20: 408-415.
14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
15. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
16. Rowan K, (2010) Fertility preservation during treatment is a growing issue for women. J Natl Cancer Inst 102: 294-296.
17. Schover LR, (2009) Rates of postcancer parenthood. J Clin Oncol 27: 321-322.
18. Mariotto AB, Rowland JH, Yabroff KR, Scoppa S, Hachey M, et al. (2009) Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 18: 1033-1040.
19. Nagar S, (2010) Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy. Adv Exp Med Biol 678: 124-132.
20. Bishop JB, (2003) Female-specific reproductive toxicities following preconception exposure to xenobiotics. Adv Exp Med Biol 518: 1-9.
21. Cooper GM, Nickerson DA, Eichler EE, (2007) Mutational and selective effects on copy-number variants in the human genome. Nat Genet 39: S22-29.
22. Gregory TR, (2004) Insertion-deletion biases and the evolution of genome size. Gene 324: 15-34.
23. Witt KL, Bishop JB, (1996) Mutagenicity of anticancer drugs in mammalian germ cells. Mutat Res 355: 209-234.
24. Grady MC, (2006) Preconception and the young cancer survivor. Matern Child Health J 10: S165-168.
25. Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, et al. (2005) Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 122: 303-315.
26. Jurisicova A, Lee HJ, D'Estaing SG, Tilly J, Perez GI, (2006) Molecular requirements for doxorubicin-mediated death in murine oocytes. Cell Death Differ 13: 1466-1474.
27. Perez GI, Knudson CM, Leykin L, Korsmeyer SJ, Tilly JL, (1997) Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat Med 3: 1228-1232.
28. Perez GI, Robles R, Knudson CM, Flaws JA, Korsmeyer SJ, et al. (1999) Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat Genet 21: 200-203.
29. Veitia RA, Gluckman E, Fellous M, Soulier J, (2007) Recovery of female fertility after chemotherapy, irradiation, and bone marrow allograft: further evidence against massive oocyte regeneration by bone marrow-derived germline stem cells. Stem Cells 25: 1334-1335.
30. Stovall M, Donaldson SS, Weathers RE, Robison LL, Mertens AC, et al. (2004) Genetic effects of radiotherapy for childhood cancer: gonadal dose reconstruction. Int J Radiat Oncol Biol Phys 60: 542-552.
31. Ben-Aharon I, Bar-Joseph H, Tzarfaty G, Kuchinsky L, Rizel S, et al. (2010) Doxorubicin-induced ovarian toxicity. Reprod Biol Endocrinol 8: 20.
32. Ting AY, Petroff BK, (2010) Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat. J Assist Reprod Genet 27 (11): 591-597.
33. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, et al. (2010) Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 102: 14-25.
34. Aluise CD, Sultana R, Tangpong J, Vore M, St Clair D, et al. (2010) Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Adv Exp Med Biol 678: 147-156.
35. McLoon LK, Wirtschafter JD, (2001) Doxil-induced chemomyectomy: effectiveness for permanent removal of orbicularis oculi muscle in monkey eyelid. Invest Ophthalmol Vis Sci 42: 1254-1257.
36. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA, (2010) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer.
37. Patel N, Joseph C, Corcoran GB, Ray SD, (2010) Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol 245: 143-152.
38. Critchley HO, Wallace WH, (2005) Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr pp. 64-68.
39. Falkenberg JH, Iaizzo PA, McLoon LK, (2002) Muscle strength following direct injection of doxorubicin into rabbit sternocleidomastoid muscle in situ. Muscle Nerve 25: 735-741.
40. Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, et al. (2008) Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A 105: 8215-8220.
41. Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, et al. (2009) Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) 1: 988-1007.
42. Dalvi A, Lucki I, (1999) Murine models of depression. Psychopharmacology (Berl) 147: 14-16.
43. Madanat-Harjuoja LM, Malila N, Lahteenmaki PM, Boice JD Jr, Gissler M, et al. (2010) Preterm delivery among female survivors of childhood, adolescent and young adulthood cancer. Int J Cancer 127: 1669-1679.
44. Bishop JB, Morris RW, Seely JC, Hughes LA, Cain KT, et al. (1997) Alterations in the reproductive patterns of female mice exposed to xenobiotics. Fundam Appl Toxicol 40: 191-204.
45. Katoh MA, Cain KT, Hughes LA, Foxworth LB, Bishop JB, et al. (1990) Female-specific dominant lethal effects in mice. Mutat Res 230: 205-217.
46. Listed NA, (1992) Some chemotherapy agents cause female-specific genetic damage. Oncology (Williston Park) 6: 84-85.
47. Trasler JM, Hales BF, Robaire B, (1986) Chronic low dose cyclophosphamide treatment of adult male rats: effect on fertility, pregnancy outcome and progeny. Biol Reprod 34: 275-283.
48. Jacquet P, Averbach A, Stuart OA, Chang D, Sugarbaker PH, (1998) Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol 41: 147-154.
49. DeVita VT Jr, Chu E, (2008) A history of cancer chemotherapy. Cancer Res 68: 8643-8653.
50. Heck KE, Schoendorf KC, Ventura SJ, Kiely JL, (1997) Delayed childbearing by education level in the United States, 1969-1994. Matern Child Health J 1: 81-88.
51. Lai HC, Yeh YC, Ting CT, Lee WL, Lee HW, et al. (2010) Doxycycline suppresses doxorubicin-induced oxidative stress and cellular apoptosis in mouse hearts. Eur J Pharmacol 644: 176-187.
52. Montaigne D, Marechal X, Preau S, Baccouch R, Modine T, et al. (2010) Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium. Mitochondrion 11 (1): 22-26.
53. Kasapovic J, Pejic S, Stojiljkovic V, Todorovic A, Radosevic-Jelic L, et al. (2010) Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide. Clin Biochem 43: 1287-1293.
54. Perez GI, Acton BM, Jurisicova A, Perkins GA, White A, et al. (2007) Genetic variance modifies apoptosis susceptibility in mature oocytes via alterations in DNA repair capacity and mitochondrial ultrastructure. Cell Death Differ 14: 524-533.
55. Chabi B, Ljubicic V, Menzies KJ, Huang JH, Saleem A, et al. (2008) Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell 7: 2-12.
56. Chinnery PF, (1993) Mitochondrial Disorders Overview.
57. Hofhaus G, Gattermann N, (1999) Mitochondria harbouring mutant mtDNA-a cuckoo in the nest? Biol Chem 380: 871-877.
58. St John JC, Facucho-Oliveira J, Jiang Y, Kelly R, Salah R, (2010) Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells. Hum Reprod Update 16: 488-509.
59. White DJ, Wolff JN, Pierson M, Gemmell NJ, (2008) Revealing the hidden complexities of mtDNA inheritance. Mol Ecol 17: 4925-4942.
60. Chinnery PF, (2010) Mitochondrial Disorders Overview. Gene Reviews.
61. Tachibana M, Sparman M, Sritanaudomchai H, Ma H, Clepper L, et al. (2009) Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461: 367-372.
62. Perez GI, Trbovich AM, Gosden RG, Tilly JL, (2000) Mitochondria and the death of oocytes. Nature 403: 500-501.
63. Wyrobek AJ, Mulvihill JJ, Wassom JS, Malling HV, Shelby MD, et al. (2007) Assessing human germ-cell mutagenesis in the Postgenome Era: a celebration of the legacy of William Lawson (Bill) Russell. Environ Mol Mutagen 48: 71-95.
64. Langenhuijsen MM, (1984) Neutrophils with ring-shaped nuclei in myeloproliferative disease. Br J Haematol 58: 227-230.
65. Stavem P, (1985) Neutrophils with ring-shaped nuclei in myeloproliferative disease. Br J Haematol 59: 559.
66. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, et al. (2000) Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6: 1109-1114.
67. Paris F, Perez GI, Fuks Z, Haimovitz-Friedman A, Nguyen H, et al. (2002) Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med 8: 901-902.
68. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, et al. (2001) Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 28: 355-360.
69. Takai Y, Canning J, Perez GI, Pru JK, Schlezinger JJ, et al. (2003) Bax, caspase-2, and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo. Endocrinology 144: 69-74.
70. Perez GI, Jurisicova A, Wise L, Lipina T, Kanisek M, et al. (2007) Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice. Proc Natl Acad Sci U S A 104: 5229-5234.
71. Perez GI, Jurisicova A, Matikainen T, Moriyama T, Kim MR, et al. (2005) A central role for ceramide in the age-related acceleration of apoptosis in the female germline. Faseb J 19: 860-862.
72. Perez GI, Tao XJ, Tilly JL, (1999) Fragmentation and death (a.k.a. apoptosis) of ovulated oocytes. Mol Hum Reprod 5: 414-420.
73. Kujjo LL, Laine T, Pereira RJ, Kagawa W, Kurumizaka H, et al. (2010) Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51. PLoS One 5: e9204.
74. Ren D, Navarro B, Perez G, Jackson AC, Hsu S, et al. (2001) A sperm ion channel required for sperm motility and male fertility. Nature 413: 603-609.
75. Karl T, Pabst R, von Horsten S, (2003) Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55: 69-83.
76. Nagy A, Gertsenstein M, Vintersten K, Behringer R, (2008) Karyotyping mouse cells. Cold Spring Harbor Protocols Cold Spring Harbor Laboratory Press.